News & Trends - Pharmaceuticals
Organon ANZ unveils dedicated innovation team
Pharma News: In a strategic move, Organon ANZ has reshaped its organisational structure to pave the way for greater employee development and business growth. The company has introduced a visionary Strategy and Business Excellence team, marking the debut of their dedicated innovation function. This dynamic initiative seeks not only to strengthen the company’s position in the healthcare industry but also to empower women’s healthcare needs while building a foundation for a better society.
Nirelle Tolstoshev, Managing Director of Organon ANZ, stated “We believe that being a leading partner in women’s healthcare not only supports the well-being of women but also lays the groundwork for a stronger and healthier society.”
As Organon ANZ celebrated its second anniversary in June, the time was ripe for a strategic review, a period that marked the commencement of their next phase of growth.
Ms Tolstoshev further explained, “We recognised the importance of re-evaluating our integration across the entire business to ensure that we possess the future-ready skills and structure necessary to cater to the evolving needs of healthcare providers and patients.”
The aim was clear: to remain agile and adaptable, staying ahead in a rapidly changing market and regulatory landscape.
The crown jewel of this transformation is the newly established Strategy & Business Excellence team. This group will drive the company forward by fostering fast-moving innovation and streamlined decision-making processes. Headed by Meaghan Clarke, this team is entrusted with critical responsibilities, including organisational strategy, business development, pipeline planning, data & insights, and customer experience.
Ms Clarke brings a wealth of expertise and a sharp business acumen from her extensive experience in the pharmaceutical sector across multiple commercial and therapeutic areas. Her leadership promises to be a guiding force in steering Organon ANZ towards new horizons of success.
“At the core of Organon’s inception lies a commitment to listening – to our patients, customers, and our workforce. We value feedback and have learned through employee engagement surveys and other mechanisms that our business must adapt continuously to anticipate our customers’ needs,” expressed Ms Tolstoshev with unwavering determination.
Organon ANZ’s unwavering dedication to its employees and customers has undoubtedly contributed to its remarkable growth. Now, with the formation of the Strategy & Business Excellence team, the company is poised to take innovation to new heights, ensuring that its culture remains vibrant and that it attracts the best talent to nurture its in-house expertise.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics
Government’s rejection of COVID Royal Commission a stark contrast to the UK and NZ
The Albanese government has dismissed the Senate legal and constitutional committee’s proposal for a COVID-19 pandemic royal commission with one […]
MoreNews & Trends - Biotechnology
AusBiotech and MTPConnect unite for landmark Summit on the nation’s biotech and medtech future
AusBiotech and MTPConnect have announced an ambitious new collaboration to host Australia’s first National Biotech and Medtech Development and Commercialisation […]
MoreNews & Trends - Pharmaceuticals
Targeted therapy with Astellas’ Xtandi improves prostate cancer outcomes for Aussie patients: New study
Pharma News: New research from the led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) […]
More